Many promising peptides fail because they degrade too easily. This limits their usefulness in drug design and creates ...
There has been a recent revival in interest in peptide therapeutic development, with five of the top-selling drugs being peptides or proteins (Enbrel, Remicade, Humira, Avastin, MabThera) and many ...
A major problem in solid-phase peptide synthesis (SPPS) is aggregation and poor solvation leading to incomplete deprotection and/or coupling steps, resulting in low crude purity peptides. 1 This ...
The global peptide therapeutics market size is calculated at USD 54.57 billion in 2026 and is expected to reach around USD 81.5 billion by 2034, growing at a CAGR of 5.35% for the forecasted ...
In 1901, the German chemist Emil Fischer synthesized the first pure dipeptide molecule; more than half a century later, most chemists were still using the same technique of adding and removing ...
Vapourtec’s Peptide-Builder, a fully automated, high-throughput benchtop peptide synthesiser, has been designed to redefine solid-phase peptide synthesis (SPPS). Compact, efficient and intuitive, it ...
Biotage, a leading supplier of tools and technology for analytical, medicinal and peptide chemistry, has introduced an innovative, new instrument for peptide professionals at the 2011 American Peptide ...
SHANGHAI--(BUSINESS WIRE)--AmbioPharm, a worldwide leader in peptide API CDMO services, continues growth to meet capacity demands for late phase and commercial peptide production. A reliable peptide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback